Juliette Johnson

Fluxion Biosciences (United States)

Papers

2

Total Citations

69

H-Index

2

About

Juliette Johnson has established herself as a pioneering researcher at the intersection of microfluidics, electrophysiology, and pharmaceutical drug discovery. Her work centers on developing and refining automated patch clamp technologies that revolutionize how ion channel physiology and pharmacology are studied at scale. Most notably, Johnson contributed to the development and evaluation of IonFlux, a microfluidic patch clamp system assessed using the human *Ether-à-go-go* Related Gene (hERG) channel — a critical target in cardiac safety pharmacology — earning 40 citations for that foundational work. Her subsequent research on well-plate microfluidic automation further advanced the field, demonstrating how continuous flow environments can yield rapid, consistent, and reproducible ion channel data relevant to pharmaceutical screening, accumulating an additional 29 citations. Together, these contributions address longstanding challenges in drug discovery: balancing throughput, cost-efficiency, and predictive accuracy when measuring membrane current changes. Johnson's innovations have meaningfully shaped modern high-throughput screening pipelines, offering the pharmaceutical industry more reliable tools to both identify promising therapeutic compounds and flag potential cardiotoxic side effects earlier in the development process.

Research Focus

Key Achievements

2
H-Index
2
Papers
69
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
IonFlux: A Microfluidic Patch Clamp System Evaluated with Human <i>Ether-à-go-go</i> Related Gene Channel Physiology and Pharmacology
40 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Fluxion Biosciences (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago